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Abstract
Background: Systematic reviews are vital to the pursuit of evidence-based medicine within healthcare. Screening
titles and abstracts (T&Ab) for inclusion in a systematic review is an intensive, and often collaborative, step. The use
of appropriate tools is therefore important. In this study, we identified and evaluated the usability of software tools
that support T&Ab screening for systematic reviews within healthcare research.
Methods: We identified software tools using three search methods: a web-based search; a search of the online
“systematic review toolbox”; and screening of references in existing literature. We included tools that were
accessible and available for testing at the time of the study (December 2018), do not require specific computing
infrastructure and provide basic screening functionality for systematic reviews. Key properties of each software tool
were identified using a feature analysis adapted for this purpose. This analysis included a weighting developed by a
group of medical researchers, therefore prioritising the most relevant features. The highest scoring tools from the
feature analysis were then included in a user survey, in which we further investigated the suitability of the tools for
supporting T&Ab screening amongst systematic reviewers working in medical research.
Results: Fifteen tools met our inclusion criteria. They vary significantly in relation to cost, scope and intended user
community. Six of the identified tools (Abstrackr, Colandr, Covidence, DRAGON, EPPI-Reviewer and Rayyan) scored
higher than 75% in the feature analysis and were included in the user survey. Of these, Covidence and Rayyan were
the most popular with the survey respondents. Their usability scored highly across a range of metrics, with all
surveyed researchers (n = 6) stating that they would be likely (or very likely) to use these tools in the future.
Conclusions: Based on this study, we would recommend Covidence and Rayyan to systematic reviewers looking
for suitable and easy to use tools to support T&Ab screening within healthcare research. These two tools
consistently demonstrated good alignment with user requirements. We acknowledge, however, the role of some of
the other tools we considered in providing more specialist features that may be of great importance to many
researchers.
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Background
Since the 1980‘s the field of research synthesis has
grown exponentially. As the number of primary research
papers increases, so does the need for secondary re-
search that consolidates and summarises their findings.
Systematic reviews are a form of research synthesis that
use systematic methods to find, critically analyse and
collate the results of existing studies. In healthcare, sys-
tematic reviews are vital to the pursuit of evidence-based
medicine; they identify gaps in knowledge and agree-
ment between different studies and provide the evidence
required to move confidently from interventions to pol-
icy [1, 2]. A report published in 2007 identified 300 sys-
tematic reviews indexed in Medline in 1 month [3]. In
2017, 11,000 systematic reviews were registered with
PROSPERO [4].
Systematic reviews necessitate screening large num-
bers of articles to ascertain whether they meet specified
inclusion criteria. The first round of screening, typically
title and abstract (T&Ab) screening, can be time-
consuming. To divide the workload and enable all of the
articles to be screened more than once - in accordance
with best practice guidelines - this stage of the review is
often shared between several collaborators [5, 6]. In re-
sponse to the growing need for support for T&Ab
screening, a large number of software tools have been
developed to facilitate this stage of the systematic review
process. These tools are a mix of commercial and aca-
demic projects, which vary greatly in style, scope and
cost. The selection of the most appropriate tool to sup-
port a review project or research collaboration will de-
pend on the specific skill set and processes of the local
research environment. Previous studies have only
reviewed tools that support the entire systematic review
process [7, 8], and in each case have largely focussed on
tools targeted at specific fields of research (such as agri-
culture or software engineering).
This scoping review aims to identify, describe and evalu-
ate the usability of the available software tools that sup-
port the T&Ab screening process for healthcare research
to enable researchers to select the most appropriate for
their work. We develop a feature analysis framework to
compare software applications for T&Ab screening, using
input from researchers to determine the areas of most im-
portance. Additionally, the user experience of several tools
is investigated by a survey of several researchers.
This work may be of particular interest to researchers
new to systematic reviews, looking to change their ap-
proach to screening or those in the position of selecting
an appropriate tool for a collaboration.
Methods
The study had four stages to identify and evaluate the
suitability of currently available software tools to support
T&Ab screening. The stages are: a search for relevant
tools, screening for suitability, a feature analysis and a
user survey.
Search strategy
We developed a search strategy to identify software relevant
to this study. Firstly, a web search was conducted. Using a
private browser, the first five pages of a google search -
“systematic review screening software” - were searched for
links or references to relevant software tools. Secondly, we
searched the systematic review toolbox, which contains a
list of 157 software tools [9]. We obtained a list of suitable
tools by using the filter “study selection”. Finally, we in-
cluded software tools mentioned in two previous reviews of
tools to support systematic reviews [7, 8]. The search was
carried out in December 2018.
The identification of tools for inclusion
A list of five criteria for inclusion was developed by
three of the authors (HH, JUS and SG); the latter criteria
were applied only if the former were met. One re-
searcher (HH) applied the criteria to all the software
tools identified by the search. The inclusion criteria, in
order of application, are listed below.
1. The software is currently accessible
i. The website hosting this software tool must
currently exist
ii. It is possible either to access this tool online or
download and install the tool
2. It was possible to test the software for free
i. This requires that either the tool is free to use
or there is a free trial available
ii. Where a free trial was not automatically
available, then the company or organization
hosting the application was contacted to request
one
3. The software has reasonable system requirements
i. The user is not required to provide specific
computing infrastructure (such as an SQL
server) in order to use the software
4. Provide basic screening functionality for SRs
i. The tool can be used to screen references (at
least by title and abstract). This requires that
there is additional functionality above what is
provided by a reference manager
5. The software is working (it is possible to carry out a
test project)
i. The user must be able to carry out basic tasks
(such as importing references) with the tool
Feature analysis
Conducting a feature analysis of a collection of software
applications with similar applications is a well-recognised
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method in software engineering [10, 11]. This involves de-
veloping a list of relevant features that a software tool de-
veloped for a specific purpose, such as T&Ab screening,
might be expected to possess. Each feature is then assessed,
for each tool being considered, to generate a score. Analysis
of the individual features also provides the evaluator with
an insight into the strengths and weaknesses of the individ-
ual software tools and the overall group.
As part of the DESMET method (a methodology for
evaluating software engineering methods and tools) [12],
guidelines for conducting feature analyses of software
applications were published by Kitchenham and col-
leagues in 1993 [13, 14]. The feature analysis developed
in this study uses the “screening mode design” described
in these guidelines. A list of relevant features was de-
vised by one researcher (HH), in part drawing on previ-
ous feature analyses of software tools for systematic
reviews [8], as well as consulting with medical re-
searchers involved in systematic reviews. Five re-
searchers participated in a discussion group during
which a list of potential features were presented; the re-
searchers added, removed and revised the list of features
until a consensus was reached. The features were
grouped into themes, such as “Economic” or “Process
Management”, providing an easy way to identify areas of
strength and weakness in each tool. A single evaluator
(HH) devised assessment criteria - which can be found
in the supplementary materials (Additional file 1). These
were reviewed by a second researcher prior to the collec-
tion of information and feature scoring for each tool.
Each software tool was evaluated using test projects set
up for this purpose. For each feature, software tools were
given a score of “0” if the feature did not exist, “1” if the
feature existed and “2” if the feature was well
implemented.
In order to make the overall score for the feature ana-
lysis more reflective of the needs of systematic reviewers
in healthcare, a weighting for the features was devised
collaboratively by a group of medical researchers. A
similar weighting has previously been developed for the
assessment of systematic review support tools within
software engineering [8]. Two researchers with experi-
ence of systematic reviews were interviewed and a fur-
ther five participated in a discussion group. The
researchers were asked to rate features as “Mandatory”
(M), “Highly Desirable” (HD), “Desirable” (D), “Nice to
Have” (N) or Irrelevant (I). The final rating for each fea-
ture was determined by taking the consensus view of the
seven researchers. To achieve an overall score for each
software tool, the feature scores (0–2) were multiplied
by the relevant weighting (0–4, irrelevant-mandatory).
The raw score for each tool, achieved by summing the
weighted score of each feature, was converted to a per-
centage of the total possible score. This is necessary, as
some features (such as “easy installation”) were not
applicable to every software tool evaluated. Radial
diagrams, which plot the results of the weighted feature
analysis by theme, were plotted for the six best perform-
ing tools.
User survey
We developed a user survey to investigate the opinions of
medical researchers involved with systematic reviews on
the suitability of the tools. The best performing tools,
those scoring higher than 75% in the feature analysis, were
included in the user survey. Potential survey participants
were recruited using a snowballing approach, from which
we were able to select a range of experience levels and car-
eer stages. Eight researchers were approached and six
agreed to take part in the user survey.
A standard form was developed to record the re-
sponses of six researchers to the user survey; this can be
found in the supplementary materials (Additional file 2).
All the survey respondents had some experience of
working with systematic reviews and they encompassed
a range of experience levels and career stages. The re-
searchers were asked to provide some information about
themselves, their research experience and their attitudes
towards software tools for T&Ab screening. They were
then asked to run a trial project on a selection of the
software tools and report on their experience. For each
tool, the researchers were asked to indicate how straight-
forward a series of seven actions were to complete. The
actions were:
1. Creating an account
2. Creating a systematic review project
3. Importing references
4. Inviting collaborators to join the project
5. Carrying out T&Ab screening on the references
6. Exporting the screened references
7. Finding and using the help section
The ease of completing each action was ranked on a
scale of 1 to 5 (where 1 is very difficult and 5 is very
easy). For each tool, we calculated the “action score”,
which is the average score given by the respondent over
the seven actions. Radial diagrams were plotted to show
the performance of each tool for each of the seven ac-
tions. Additionally, an overall score was given by each
researcher to each tool on a scale of 1 to 5 (where 1 is
very bad and 5 is very good). Additionally, the re-
searchers compared the tools to using a spreadsheet and
indicated if they would be likely to use the tool them-
selves or recommend it to a colleague.
The survey respondents also provided free text com-
ments on the strengths, weaknesses and their general
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impression of each tool. Issues or topics mentioned by
more than one respondent were identified.
Results
Identification of software tools
After deduplication, the search strategy identified 35
software tools that had been characterised by others as
supporting the screening phase of systematic reviews. A
full list of these software tools, as well as information on
where they can be found, is given in the supplementary
materials (Additional file 3). Of these, 20 were excluded
in the screening process by one reviewer (HH). The
most common reason for excluding a tool from the
study was that it did not have T&Ab screening function-
ality, for example the tool JBI SUMARI only supports
full text screening and RevMan5 does not provide any
screening functionality beyond what is offered by a refer-
ence manager. Six software tools were excluded because
it was not possible to access them; in most cases because
the website hosting the tool is no longer supported (for
example GAPScreener). For two tools, DistillerSR or
EROS, it was not possible to obtain a free trial, so these
were not investigated further. Additionally, SluRp and
SLR-Tool were excluded as they required the setup of
an SQL server. Finally, although SESRA fulfilled all the
other criteria, it was not possible to upload citations to
this tool and carry out a test project, so this tool was
also excluded. After screening 15 software tools were in-
cluded in this study (Fig. 1). The included tools ranged
from those providing a basic system exclusively for
T&Ab screening (for example Abstrackr) to platforms
able to offer support for several stages of the systematic
review process (for example EPPI-reviewer).
Feature analysis
The features of the software tools assessed in this study
and their weighting are listed in Table 1, they are split
into seven themes for the purpose of analysis.
The features of each software tool are summarised in
the traffic light diagram (Fig. 2). Two of the features -
supports title and abstract screening (T3-F2) and has an
include and exclude option (T7-F1) - are implemented
well in all the tools. In both cases, these features are en-
sured by the inclusion criteria and do not contribute to
the score assigned to the software tools in the subse-
quent analysis.
A large amount of variation was seen between the 15
software tools. For the features grouped under the theme
of “screening features”, DRAGON and Rayyan had all
these features rated as well implemented (green), how-
ever, PARSIFAL only had two of them implemented
(and only one implemented well).
Some of the features considered were very common
and were implemented in the majority of tools. For
example, all the tools considered supported multiple
projects (T4-F2) and all but one implemented this well.
The only tool that did not implement this well was
EPPI-reviewer, as users were required to pay more for
additional projects. More generally, most of the tools
had the features grouped under the theme “screening
support” (T3) well implemented. This reflects that most
of the tools considered support multiple stages of sys-
tematic reviews.
There are, however, features that were not imple-
mented for many of the 15 tools evaluated. These in-
clude providing a mobile (or tablet) application (T2-F5)
- which was only well implemented in one tool (Rayyan)
- and supporting the import of .pdf files for full text
screening (T5-F4) - which was only implemented well in
two tools (CADIMA and Covidence).
The 15 software tools are ranked from highest to low-
est in Fig. 3 according to the summary score based on
the feature information (Fig. 2) and the weighting
(Table 1).
The scores for the weighted feature analysis, as shown
in Fig. 3, ranged from 88% (Rayyan and Covidence) to
36% (StArt). All of the tools designed specifically for
non-medical researchers - including CADIMA (agricul-
ture) and PARSIFAL (software engineering) – scored
less than 75% in the feature analysis. Additionally, both
of the tools that require the user to use the R program-
ming language, METAGEAR and revtools, scored less
than 75%.
Radial diagrams, showing the scores of the six best per-
forming tools across the eight themes (as identified in
Table 1) can be found in the (Additional file 4: Figure S1).
User survey
Six healthcare researchers ran a test project in each of
the six highest scoring software tools from the feature
analysis. A brief summary of the experience and attitude
of the survey respondents towards software tools for
T&Ab screening is given in Table 2.
All six respondents completed the survey; however, one
respondent was unable to use EPPI-reviewer due to prob-
lems installing the Silverlight application. Therefore, only
five responses were available for the analysis of this tool.
The action and overall scores obtained for each tool,
using the survey responses, are given in Fig. 4a and b re-
spectively; both are given as percentages of the highest
possible score.
For both measures shown in Fig. 4, Covidence received
the highest score (93 and 88% respectively). Rayyan and
Abstrackr both scored 86% on the action score, however,
for the overall score Rayyan performed significantly bet-
ter than Abstrackr (79 and 62% respectively). Colandr,
DRAGON and EPPI-reviewer consistently performed
worse than the other three tools.
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Additional file 5: Figure S2 plots the breakdown of the
average scores for each of the seven actions for each of
the seven actions. Whilst in most categories Rayyan and
Abstrackr had similar performance (Additional file 5:
Figure S2(f) and (a)), Rayyan performed significantly
worse for the action “find and use the help section”, in-
dicating that several respondents had problems with this
task. However, the respondents’ free text comments sug-
gest that this was not a significant issue. Comments in-
cluding - “I wouldn’t have looked for one <a help
section>” and “it’s fairly self-explanatory” – suggest that
for this software tool the users did not find the lack of a
good quality help section particularly important when
giving their overall scores. Abstrackr, although it per-
formed well in each of the seven action categories, did
not perform as well in the overall scores. Free text
comments from the respondents, describe Abstrackr as
“basic”, “informal” and not having “as much functionality
as other tools”, which may explain the lower overall
rating.
Table 3 shows the common themes that emerged from
the comments made about each tool with indicative
quotations. All of the survey respondents identified Ray-
yan as a tool that was simple or easy to use. This pro-
vides good supporting evidence for the high overall
score this tool received. In contrast, all of the survey re-
spondents indicated that DRAGON was hard to setup
compared to other tools; five (out of six) respondents
stated that they would require training in order to use
DRAGON effectively. Similarly, five of the respondents
indicated that they found EPPI-reviewer difficult to use
(note that only five respondents were able to use EPPI-
Fig. 1 Software tool flow diagram
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reviewer) and that they would require training to use it
effectively.
Four respondents mentioned that Colandr was slow to
process decisions and that the excluded decisions did
not disappear immediately. As saving time was identified
(by three researchers) as a motivator for their interest in
software for T&Ab screening, a software tool with a slow
response is unlikely to score highly.
All the respondents indicated that Abstrackr, Rayyan
and Covidence performed well and made screening eas-
ier (or much easier) than using a spreadsheet. The over-
all view of Colandr was that the experience of using it
for T&Ab screening is comparable to using a spread-
sheet. However, there was variation in views with some
respondents positive about its performance whilst others
did not feel that it was a useful tool. Similarly, whilst
overall the respondents thought that using EPPI-
reviewer or DRAGON would be more difficult than
using a spreadsheet, the extent of this varied between
the respondents. Several of the respondents that scored
EPPI-reviewer or DRAGON highly mentioned the po-
tential to carry out complex tasks, using some of the
additional features and flexibility, with these tools. Other
respondents, however, focussed on the difficulties of
Table 1 Overview of feature analysis
Themes Features Code Weightinga
Economic The tool does not require financial payment to use. T1-F1 HD
Ease of Introduction and Setup The tool has straightforward system requirements T2-F1 HD
There is an installation guide (where applicable) T2-F2 D
There is a tutorial/help section T2-F3 D
The software does not require user to code T2-F4 HD
There is an app for mobile/tablet T2-F5 D
Systematic Review Support Supports deduplication T3-F1 D
Supports title and abstract screening T3-F2 –
Supports full text screening T3-F3 D
Supports data extraction T3-F4 N
Supports other stages of the review T3-F5 N
Process Management Support for multiple users T4-F1 M
Support for multiple projects T4-F2 D
Choice of single or double screen before progression T4-F3 HD
Work Allocation T4-F4 HD
Management of roles T4-F5 D
Reference Management Import of References T5-F1 –
Export of References T5-F2 M
Export of Decisions T5-F3 M
Import of .pdfs T5-F4 D
Workflow The tool is flexible to varying workflow T6-F1 HD
Short User Set-up (before screening can begin) T6-F2 D
Progress is monitored and fed back to user T6-F3 HD
Screening Features Include/Exclude Option T7-F1 –
Key word highlighting (or similar) T7-F2 D
Can filter citations by category T7-F3 D
Can search citations (i.e. search engine) T7-F4 D
Further categorize/label references T7-F5 HD
Blind screeners to decisions of others. T7-F6 HD
Conflict Resolutions T7-F7 HD
Citation classification/ranking tool (clustering/ML) T7-F8 N
Security Insecure website T8-F1 HD
Features without a weighting are covered by the inclusion criteria and are found in all the included software tools
aAbbreviations: M Mandatory, HD Highly Desirable, D Desirable, N Nice to Have, I Irrelevant
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getting started and navigating a more difficult user
interface.
Finally, responses to the question ‘how likely are you to
use the tool in future?’ varied. While all of the respondents
said they would be likely to use Rayyan, there was less con-
sensus about using Covidence. Several free text comments
from the respondents mentioned the cost of using Covi-
dence – “so expensive”, “I wouldn’t be able to choose to
use this tool, since there is a cost” – as a reason why they
would not typically use this tool for systematic reviews.
Discussion
Key findings
We have identified a large number of software tools that
support T&Ab screening for systematic reviews within
healthcare research. Where possible we have tested the
software and identified relevant features. The six highest
scoring tools were trialled by a group of six healthcare
researchers with experience of systematic reviews. Out
of all the software tools considered, Covidence and Ray-
yan emerged as the most suitable tools to support T&Ab
Fig. 2 Traffic light diagram of software features. Red indicates that the feature is not present, orange that it has been implemented, and green
that it has been implemented well. Feature codes can be seen in Table 1
Fig. 3 Scores from the weighted feature analysis, with the software tools ranked from lowest to highest. The scores are given as a percentage of
the total possible score
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screening for systematic reviews in both the feature ana-
lysis and the user survey.
Findings in the context of other research
Other reviews of software tools to support system-
atic reviews have reported different findings. An ana-
lysis by Kohl et al. [7] of software tools to support
the conduct and reporting of systematic reviews
found CADIMA to be the most useful open access
tool. A feature analysis of tools to support systematic
reviews in software engineering carried out by Mar-
shall et al. [8] recommended SLuRp as the highest
scoring tool.
CADIMA and SluRp were amongst the software tools
identified during the search for this study; both were
eliminated during the early stages of the review process.
SluRp was not considered appropriate for this study, as
its use requires the setup of an SQL server. CADIMA
was evaluated in the feature analysis, but did not score
highly enough to be included in the user survey. In
Table 2 Description of survey respondents
Categories Respondent characteristic Number (n = 6) Percentage
Research Position Medical Student 1 16.7%
PhD Student 1 16.7%
Postdoctoral Researcher 3 50.0%
Medical Librarian 1 16.7%
Systematic Review Experience Carried out T&Ab Screening 6 100%
Managed T&Ab Screening 4 66.7%
Led a Systematic Review 4 66.7%
Number of Systematic Review Projects in the Last Year 0 to 2 1 16.7%
3 to 5 2 33.3%
6 to 10 2 33.3%
More than 10 1 16.7%
Current T&Ab Screening System Reference Manager 3 50.0%
Spreadsheet 1 16.7%
Software Package 2 33.3%
Previous Software experience Used software previously 6 100.0%
Rayyan 5 83.3%
Covidence 2 33.3%
Preferences for T&Ab screening Would prefer to use a software tool 6 100%
Believe a software tool would be well received by collaborators 6 100%
Summary of the experiences of the survey respondents with systematic reviews and their attitudes towards software to support T&Ab screening
Fig. 4 The performance of the six software tools evaluated in the user survey are compared using a the action score (the average score over the
seven key actions) and b the overall score (a single score provided for each tool indicating overall experience)
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particular, CADIMA did not have many of the
screening features that were considered very import-
ant by the systematic reviewers we consulted, such as,
allowing users to add additional labels and categories
other than simply “include” and “exclude”. The dis-
parities in outcome not only reflect the different
evaluation frameworks used, but also the diverse
priorities of each academic community of systematic
reviewers.
The studies by Kohl [7] and Marshall [8] differ signifi-
cantly from this one in scope (T&Ab screening) and tar-
get audience (healthcare researchers). Both Kohl and
Marshall only consider tools that support the entire sys-
tematic review process. The study by Kohl focuses on
Table 3 Identified strengths and weaknesses of the software
Strengths Weaknesses
Themes Supporting Quotations Themes Supporting Quotations
Rayyan Simple and easy to use. (6) “So easy to use..”
“Very simple to import and
export.”
Too much content on the
side panel. (2)
“I don’t think the sections of the left
side of the screen are helpful”
“<it suggests> keywords to include/
exclude - it means you have to start by
deleting theirs”
DRAGON Flexible/provides many
options. (3)
“..there might be many things
you could do with DRAGON...”
“..lots of flexibility in the set-up…”
Hard to setup (compared to
other tools). (6)
“Quite complicate initially to set up..”
“Not clear how to set up and use.”
Abstrackr Simple option for “basic”
screening. (5)
“..simple screening method…”
“Easy to set-up and do basic
screening.”
Poor quality user interface.
(3)
“..it felt a bit clunky..”
“Not a very professional website…”
Good for collaborating. (2) “...flexible in terms of team
working”
“Good options for collaborative
projects”
Format of exported citations.
(2)
“Exporting not as clear format as
Covidence or Rayyan.”
“..0 or − 1 as identifiers of exclude are
ambiguous..”
EPPI-
reviewer
Could be useful in large/
complex projects with
multiple stages. (3)
“..it could be helpful with all
stages of the review.”
“good coding elements … <
for>..a very large review”
Complex, difficult (not
intuitive) to use. (5)
“Makes the screening very
cumbersome.”
“Very bad layout that is not self-
explanatory.”
Difficulties getting started.
(2a)
“Difficult to access and start using…”
“Had to install software and use
internet explorer.”
Instructions/help section. (2) “..needed to watch a slow video for
instructions.”
“Could not find help section/tutorial.”
Covidence Easy to use, good user
interface. (3)
“Simple user interface…”
“.. - very clear and simple, not too
much information on the page.”
Issues with help section. (2) “..no clear help function
“…videos in help section didn’t have
subtitles …difficult to use if no
volume/in office”
Able to export into many
formats. (2)
“..able to export citations and
decisions into Excel and <
reference managers>“
“...ability to export as .ris or .csv
…”
Supports PRISMA flow
diagram (and other extra
features). (3)
“...ability to generate PRIMSA
flowchart…”
“Some of the extra features are
nice (e.g. …generate a PRISMA
diagram)...”
Colandr Easy to use/good interface.
(3)
“…aesthetically pleasing <the
interface>… and simple to use.”
“Simple user interface…”
Required to provide
exclusion reason at title and
abstract stage. (2)
“…you have to give a reason for
exclusion at title and abstract stage…”
“..having to include a reason for all
exclusions”
Easy to import citations. (2) “Simple to import.”
“...easy to import…”
Slow processing of decisions
(especially excluded citations).
(4)
“…a little slow to respond…”
“...excluded citations not
disappearing…”
Identified themes from the free text comments by survey respondents regarding the strengths and weaknesses of each tool for T&Ab screening. In each case the
number of respondents who identified the theme is indicated (themes identified by four or more respondents are in bold). Indicative quotations are provided for
each theme
aOnly five of the six respondents were able to use – and give responses for – EPPI-reviewer
Harrison et al. BMC Medical Research Methodology            (2020) 20:7 Page 9 of 12
how software tools can support systematic reviewers to
achieve best practice and transparency in reporting. The
aim of the report is to demonstrate the benefits of the
newly developed CADIMA for systematic reviewers of
genetically modified crops. The framework used to
evaluate the tools is based on the features within the
CADIMA tool.
Marshall and colleagues carried out an independent
evaluation of four “whole process” tools for systematic
reviews, used in the software engineering community. In
the analysis, a single feature addresses “study selection
and validation”. Therefore, neither of these studies pro-
vides a thorough evaluation of tools to support T&Ab
screening. Several tools evaluated in this study, including
Abstrackr, are not considered by either Kohl or
Marshall.
Strengths and limitations
The development of a new feature analysis strategy
allowed for a transparent evaluation of the available soft-
ware tools. We were able to provide detailed information
about the features available within the 15 tools evaluated
(Fig. 2) and calculate an overall score that reflects the
priorities of the user community (Fig. 3). Whilst we have
drawn heavily on existing methods, including studies of
systematic review tools in the software engineering com-
munity, this framework was specifically designed for
assessing screening tools. To the best of our knowledge,
this type of method has not been applied within the
medical research community previously.
In combining the feature analysis with the user survey,
this study provides a comprehensive evaluation of T&Ab
screening tools. The feature analysis syntheses a large
amount of detail that is not necessarily relevant to all of
our survey respondents. On the other hand, the user
survey reveals how well the tool is designed and how co-
hesive the experience of using it is, which is not mea-
sured by the feature analysis. The agreement seen
between these two methods, with Rayyan and Covidence
performing best in both, suggests that there is some cor-
relation between these two aspects.
Collecting both quantitative and qualitative data in the
user survey improved our understanding of the usability
of the screening tools. The quantitative approach allows
us to rank the tools in the analysis and directly compare
measures of performance in a variety of areas. Collecting
qualitative data as well, such as the free text about the
strengths and weaknesses of each tool, makes it possible
to investigate in more depth the reasons for the quanti-
tative scores. This highlights issues of importance to the
user community and is a useful source of information
for both the users and developers of these tools.
There are several limitations of this study, which
should be considered when interpreting its findings. This
study only considers the features offered by each tool
and the user experience they provide. We have not,
when carrying out this work, assessed other measures of
performance that may be of interest to potential users of
these tools. These include, but are not limited to, the fol-
lowing: the extent to which the tool, or its features, sup-
ports users to identify a high proportion of eligible
studies; the extent to which the design of the tool sup-
ports reviewers to accurately record their decision and
limits accidental misclassification; and the reliability with
which work done by a reviewer is recorded. Readers who
are considering using the tools discussed in this study
should consider these properties in addition to consider-
ing the user experience.
The tools identified by the search displayed consider-
able heterogeneity, which makes drawing comparisons
between them more difficult. Additionally, in this study,
we have chosen to consider the T&Ab screening stage in
isolation. While this means we were able to compare a
wide range of tools that offer that function, our findings
do not consider the potential advantages or disadvan-
tages of using a simple tool just for T&Ab screening or a
platform that supports multiple stages of the systematic
review process.
It was not possible within the scope of this project to
test all of the software tools identified. Tools that did
not provide a free trial - either automatically or when re-
quested – were not evaluated. This excluded several
well-known tools, such as, DistillerSR and EROS which
have been reported on elsewhere [7]. Additionally, this
study did not consider tools which required the user to
setup their own MySQL server (or similar) to be appro-
priate for general use. Therefore, tools including SLR-
TOOL and SLuRp have not been evaluated. Discussion
with systematic reviewers (both when developing the
weighting scheme and carrying out the user survey) re-
vealed little appetite for lengthy or complex setup of
software tools unless significant savings in time or re-
sources could be made.
This study also relied heavily on one researcher (HH),
who carried out all the screening as well as designing
and implementing the feature analysis. The dependence
on the subjective opinion of one researcher could have
biased the findings. This was mitigated in the feature
analysis by consulting other researchers. The contribu-
tions of several researchers were included when develop-
ing the list of features and a discussion group was used
to develop the weighting score. This helped to broaden
the perspective of the feature analysis, in order to be
more representative of the medical research community.
The number of participants in the user survey was
small (n = 6), therefore caution is required when inter-
preting the findings. There is also the potential for re-
spondent bias amongst the researchers who completed
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the user survey. The six respondents were all drawn
from the same research community and all but one work
in the same department. Additionally, all of the respon-
dents had some previous experience with either Rayyan
or Covidence and this may have resulted in a bias in
favour of these tools. Some of the free text comments
support this hypothesis, with Rayyan in particular de-
scribed as “familiar” by two respondents. Furthermore,
in order to simulate a “real-world” user experience when
testing the six tools included in the survey, the partici-
pating researchers were not given any external guidance
on how to use each of the tool. This would have made
the experience of using a familiar tool straightforward
when compared to an unfamiliar tool, particularly when
considering the more complex tools (such as EPPI-
reviewer or DRAGON).
It was noted by the authors, when carrying out the re-
view that this area is subject to relatively fast-paced
changes. Six of the tools identified by the search were
excluded because they no longer exist, or are no longer
accessible (see Fig. 1). During the timeframe of this
study (since November 2018), new upgrades have been
made to CADIMA (included in this study) and a web-
based version of EPPI reviewer (currently a beta-version,
more updates expected until the end of 2019, not in-
cluded in this study) has been launched. DRAGON has
only recently been developed and is not yet widely avail-
able; it is currently being rebranded as litstream and fur-
ther changes are expected in the coming months. While
the diverse range of tools available already (some of ex-
cellent quality) is encouraging, systematic reviewers will
be pleased to know that development and innovation are
ongoing in this area.
Conclusions
We identified 15 tools that can be used to support
T&Ab screening for systematic reviews in medical re-
search. Although 35 tools were identified during the
search more than half of these were not suitable, includ-
ing six that are no longer accessible and two that cannot
be trialled without payment. We developed a feature
analysis framework, the results of which showed that
there is a large amount of variation in the properties and
the quality of these tools. In the user survey, which
looked at the user experience of only the six highest per-
forming tools, a range of quality was also found.
The results of this study suggest that Covidence and
Rayyan provide the best user experience for systematic
reviewers carrying out T&Ab screening. These two tools
consistently performed well for the range of measures
we used. We acknowledge, however, the role of some of
the other tools we considered in providing more special-
ist features that may be of great importance to many
researchers.
Supplementary information
Supplementary information accompanies this paper at https://doi.org/10.
1186/s12874-020-0897-3.
Additional file 1. Feature analysis assessment.
Additional file 2. Questionnaire template.
Additional file 3. Complete list of software tools (with urls).
Additional file 4: Figure S1. Radial diagrams of six highest performing
tools in the feature analysis. The performance of the six highest scoring
software tools in the feature analysis by theme. The software tools in
each plot are (a) Abstrackr, (b) Colandr, (c) Covidence, (d) DRAGON, (e)
EPPI-Reviewer and (f) Rayyan. The themes are: (T1) Economic, (T2) Ease of
Introduction and Setup, (T3) Systematic Review Support, (T4) Process
Management, (T5) Reference Management, (T6) Workflow, (T7) Screening
Features and (T8) Security. The features included in each theme can be
found in Table 1.
Additional file 5: Figure S2. Radial Diagrams showing performance of
the six highest performing tools in the user survey. The performance of
the software tools in the user survey, considering the average score for
each of the seven actions. The software tools in each plot are (a)
Abstrackr, (b) Colandr, (c) Covidence, (d) DRAGON, (e) EPPI-Reviewer and
(f) Rayyan. The actions are: (A1) creating an account, (A2) creating a sys-
tematic review project, (A3) importing references, (A4) inviting collabora-
tors to join the project, (A5) carrying out T&Ab screening, (A6) exporting
the screened references and (A7) finding and using the help section.
Abbreviations
DESMET: A methodology for evaluating software engineering methods and
tools. The DESMET project identified nine methods of evaluation and a set of
criteria to help with the selection of an appropriate method; PRISMA: The
PRISMA statement consists of a checklist and a flow diagram that give a
minimum set of items for reporting in systematic reviews and meta-analysis.
The PRISMA flow diagram in used in this study to report the number of soft-
ware tools at each stage of the selection process; T&Ab screening: Title and
Abstract screening
Acknowledgements
We would like to thank all the researchers who contributed to this project,
both through participation in discussion groups and by completing our user
survey. We are grateful to Emma Lawlor, Sarah Kelly, Ben Paxton and
Rebecca Dennison for all their help.
We also thank ICF, EPPI-centre and Sciome for providing free trials - or ex-
tending the length of the free trials - of their software tools (DRAGON, EPPI-
reviewer and SWIFT-active screener respectively) for this project.
Authors’ contributions
HH and JUS conceived the study. HH identified the tools for inclusion and
completed the data collection and analysis. All authors contributed to the
design of the study and interpretation of the results. HH wrote the first draft
of the manuscript. JUS, SG and IK critically revised the manuscript. All authors
read and approved the final manuscript.
Funding
HH is funded by a National Institute for Health Research NIHR Systematic
Review Fellowship, RM-SR-2017-09-009. JUS is funded by a Cancer Research
UK Prevention Fellowship (C55650/A21464). The University of Cambridge has
received salary support in respect of SJG from the NHS in the East of Eng-
land through the Clinical Academic Reserve. All researchers were independ-
ent of the funding bodies and the funders had no role in study design; data
collection, analysis, and interpretation of the data; in writing of the report; or
the decision to submit the article for publication.
The views expressed in this publication are those of the author(s) and not
necessarily those of the NHS, the National Institute for Health Research or
the Department of Health and Social Care.
Availability of data and materials
All quantitative data generated or analysed during this study are included in
this published article and its supplementary information files. Free text
Harrison et al. BMC Medical Research Methodology            (2020) 20:7 Page 11 of 12
responses to the user survey are available from the corresponding author on
reasonable request.
Ethics approval and consent to participate
Not applicable.
Consent for publication
Not applicable.
Competing interests
The authors declare that they have no competing interests.
Author details
1The Primary Care Unit, Department of Public Health and Primary Care,
University of Cambridge, Cambridge, UK. 2MRC Epidemiology Unit, Institute
of Metabolic Science, Cambridge, UK. 3University of Cambridge Medical
Library, University of Cambridge School of Clinical Medicine, Cambridge, UK.
Received: 10 September 2019 Accepted: 2 January 2020
References
1. Cook DJ, Mulrow CD, Haynes RB. Systematic reviews: synthesis of best
evidence for clinical decisions. Ann Intern Med. 1997;126(5):376–80.
2. Gopalakrishnan S, Ganeshkumar P. Systematic reviews and meta-analysis:
understanding the best evidence in primary healthcare. J Fam Med Prim
Care. 2013;2(1):9–14.
3. Moher D, et al. Epidemiology and reporting characteristics of systematic
reviews. PLoS Med. 2007;4(3):e78.
4. Page MJ, Shamseer L, Tricco AC. Registration of systematic reviews in
PROSPERO: 30,000 records and counting. Syst Rev. 2018;7(1):32.
5. Julian PTH and Sally GE., Cochrane handbook for systematic reviews of
interventions. Version 5.1.0 [updated March 2011]. 2011. The Cochrane
Collaboration.
6. Moher D, et al. Preferred reporting items for systematic reviews and meta-
analyses: the PRISMA statement. PLoS Med. 2009;6(7):e1000097.
7. Kohl C, et al. Online tools supporting the conduct and reporting of
systematic reviews and systematic maps: a case study on CADIMA and
review of existing tools. Environ Evid. 2018;7(1):8.
8. Marshall C, Brereton P, Kitchenham B. Tools to support systematic reviews in
software engineering: a feature analysis. In: Proceedings of the 18th
International Conference on Evaluation and Assessment in Software
Engineering. London: ACM; 2014. p. 1–10.
9. Marshall C, Brereton P. Systematic review toolbox: a catalogue of tools to
support systematic reviews. In: Proceedings of the 19th International
Conference on Evaluation and Assessment in Software Engineering.
Nanjing: ACM; 2015. p. 1–6.
10. Grimán A, et al. Feature analysis for architectural evaluation methods. J Syst
Softw. 2006;79(6):871–88.
11. Hedberg H, Lappalainen J. A preliminary evaluation of software inspection
tools, with the DESMET method. In: Fifth International Conference on
Quality Software (QSIC'05); 2005.
12. Kitchenham B, Linkman S, Law D. DESMET: A methodology for evaluating
software engineering methods and tools, vol. 8; 1997. p. 120–6.
13. Kitchenham BA. Evaluating software engineering methods and tools, part 7:
planning feature analysis evaluation. SIGSOFT Softw Eng Notes. 1997;22(4):
21–4.
14. Kitchenham BA, Jones L. Evaluating SW Eng. methods and tools, part 8:
analysing a feature analysis evaluation. SIGSOFT Softw Eng Notes. 1997;
22(5):10–2.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in
published maps and institutional affiliations.
Harrison et al. BMC Medical Research Methodology            (2020) 20:7 Page 12 of 12
